Specifications PT-141:
Group: Peptides
Active Half-life: 120– 160 minutes
Subgroup: Injection/ powder
Dosage: 10 mg (10000 mcg)
Application: 1.25 – 1.75 mg 45 mins before activity
Product pack: 1 vial
Retains water: No
Aromatization: No
PT-141 (Bremelanotide) Peptide
PT-141, also known as Bremelanotide, is a synthetic peptide derived from the melanocortin family of peptides. Unlike compounds that primarily target vascular pathways, PT-141 has been studied for its interaction with melanocortin receptors involved in neurological signaling and behavioral responses.
Researchers have investigated PT-141 for its potential effects on sexual health, arousal pathways, and desire-related mechanisms. Scientific interest has focused on its unique mode of action within the central nervous system, making it a distinct area of study within peptide research.
Due to its interaction with melanocortin receptors, PT-141 has become a subject of ongoing research exploring neuroendocrine function, behavioral signaling, and physiological responses associated with sexual wellness and human performance.
Areas of Scientific Interest
Sexual health and wellness research
Desire and arousal pathway studies
Melanocortin receptor signaling
Neuroendocrine function research
Central nervous system response mechanisms
Behavioral and physiological regulation studies
Key Features
High-purity synthetic peptide
Melanocortin receptor-targeting compound
Lyophilized powder for enhanced stability
Batch-tested for identity and purity
Widely studied in sexual wellness and neurophysiology research
Specifications
Peptide Name: PT-141 (Bremelanotide)
Appearance: White lyophilized powder
Purity: ≥98% (HPLC)
Storage: Store refrigerated according to product guidelines
PT-141 continues to attract scientific interest for its unique interaction with melanocortin pathways and its potential role in studies involving sexual wellness, neuroendocrine signaling, and human physiological response mechanisms.
Disclaimer: This product is intended for research and laboratory use only. Research involving PT-141 is ongoing, and statements regarding potential benefits are based on scientific investigation and experimental findings. This product is not approved to diagnose, treat, cure, or prevent any disease.